Epigene Labs

Epigene Labs is a biopharmaceutical startup based in Paris, France, with a mission to revolutionize precision oncology research and drug development. The company's mCUBE platform, designed by cancer scientists for cancer scientists, aims to expedite data-driven drug discovery, biomarker identification, and patient selection. Founded in 2019 and initially incubated at the Harvard Innovation Labs, Epigene Labs has gained traction in the industry, attracting a notable €1.50M Convertible Note investment from the European Innovation Council in September 2023.

With its slogan "augmented intelligence for precision oncology research and drug development," Epigene Labs has fostered partnerships with leading cancer research institutes and biopharmaceutical companies. The company is focused on bringing better treatments to patients at an accelerated pace. Operating from both Paris and Boston, the company has positioned itself strategically in the biopharma and biotechnology space, leveraging its European roots and transatlantic presence for innovation and growth.